Cargando…

Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial

OBJECTIVE: To evaluate whether evidence-based, individualised (EBI) counselling regarding hypertension and the treatment would affect medication use in insured patients with mild hypertension in China. METHODS: We conducted a parallel-group, randomised controlled trial in two primary care centres in...

Descripción completa

Detalles Bibliográficos
Autores principales: Di, Mengyang, Mao, Chen, Yang, Zuyao, Ding, Hong, Liu, Qu, Liu, Shuiming, Guo, Hongbo, Jiang, Kunhua, Tang, Jinling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286038/
https://www.ncbi.nlm.nih.gov/pubmed/31473598
http://dx.doi.org/10.1136/bmjebm-2019-111197
_version_ 1783544809494937600
author Di, Mengyang
Mao, Chen
Yang, Zuyao
Ding, Hong
Liu, Qu
Liu, Shuiming
Guo, Hongbo
Jiang, Kunhua
Tang, Jinling
author_facet Di, Mengyang
Mao, Chen
Yang, Zuyao
Ding, Hong
Liu, Qu
Liu, Shuiming
Guo, Hongbo
Jiang, Kunhua
Tang, Jinling
author_sort Di, Mengyang
collection PubMed
description OBJECTIVE: To evaluate whether evidence-based, individualised (EBI) counselling regarding hypertension and the treatment would affect medication use in insured patients with mild hypertension in China. METHODS: We conducted a parallel-group, randomised controlled trial in two primary care centres in Shenzhen, a metropolitan city in China. Patients with mild primary hypertension, 10-year risk of cardiovascular diseases (CVDs) lower than 20% and no history of CVDs were recruited and randomly allocated to two groups. EBI plus general counselling was provided to the intervention group and general counselling alone to the control group. EBI counselling included information on the 10-year CVD risk and treatment benefit in terms of absolute risk reduction estimated for each individual and information on average side effects and costs of antihypertensive drugs. The outcomes included use of antihypertensive drugs and adherence to the treatment at 6-month follow-up, with the former being primary outcome. RESULTS: Two hundred and ten patients were recruited, with 103 and 107 allocated to the intervention and control groups, respectively. At baseline, 62.4% of the patients were taking antihypertensive drugs that were all covered by health insurance. At the end of 6-month follow-up, there was no statistically significant difference in the rate of medication use between the intervention group and the control group (65.0% vs 57.9%; OR=1.35, 95% CI: 0.77 to 2.36). The difference in adherence rate between the two groups was not statistically significant either (43.7% vs 40.2%; OR=1.15, 95% CI 0.67 to 2.00]). The results were robust in sensitivity analyses that used different cutoffs to define the two outcomes. CONCLUSIONS: The EBI counselling by health educators other than the caring physicians had little impact on treatment choices and drug-taking behaviours in insured patients with mild primary hypertension in this study. It remains unclear whether EBI counselling would make a difference in uninsured patients, especially when conducted by the caring physicians. TRIAL REGISTRATION NUMBER: ChiCTR-TRC-14004169.
format Online
Article
Text
id pubmed-7286038
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72860382020-06-15 Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial Di, Mengyang Mao, Chen Yang, Zuyao Ding, Hong Liu, Qu Liu, Shuiming Guo, Hongbo Jiang, Kunhua Tang, Jinling BMJ Evid Based Med Original Research OBJECTIVE: To evaluate whether evidence-based, individualised (EBI) counselling regarding hypertension and the treatment would affect medication use in insured patients with mild hypertension in China. METHODS: We conducted a parallel-group, randomised controlled trial in two primary care centres in Shenzhen, a metropolitan city in China. Patients with mild primary hypertension, 10-year risk of cardiovascular diseases (CVDs) lower than 20% and no history of CVDs were recruited and randomly allocated to two groups. EBI plus general counselling was provided to the intervention group and general counselling alone to the control group. EBI counselling included information on the 10-year CVD risk and treatment benefit in terms of absolute risk reduction estimated for each individual and information on average side effects and costs of antihypertensive drugs. The outcomes included use of antihypertensive drugs and adherence to the treatment at 6-month follow-up, with the former being primary outcome. RESULTS: Two hundred and ten patients were recruited, with 103 and 107 allocated to the intervention and control groups, respectively. At baseline, 62.4% of the patients were taking antihypertensive drugs that were all covered by health insurance. At the end of 6-month follow-up, there was no statistically significant difference in the rate of medication use between the intervention group and the control group (65.0% vs 57.9%; OR=1.35, 95% CI: 0.77 to 2.36). The difference in adherence rate between the two groups was not statistically significant either (43.7% vs 40.2%; OR=1.15, 95% CI 0.67 to 2.00]). The results were robust in sensitivity analyses that used different cutoffs to define the two outcomes. CONCLUSIONS: The EBI counselling by health educators other than the caring physicians had little impact on treatment choices and drug-taking behaviours in insured patients with mild primary hypertension in this study. It remains unclear whether EBI counselling would make a difference in uninsured patients, especially when conducted by the caring physicians. TRIAL REGISTRATION NUMBER: ChiCTR-TRC-14004169. BMJ Publishing Group 2020-06 2019-08-31 /pmc/articles/PMC7286038/ /pubmed/31473598 http://dx.doi.org/10.1136/bmjebm-2019-111197 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Di, Mengyang
Mao, Chen
Yang, Zuyao
Ding, Hong
Liu, Qu
Liu, Shuiming
Guo, Hongbo
Jiang, Kunhua
Tang, Jinling
Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title_full Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title_fullStr Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title_full_unstemmed Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title_short Lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in China: a randomised controlled trial
title_sort lack of effects of evidence-based, individualised counselling on medication use in insured patients with mild hypertension in china: a randomised controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286038/
https://www.ncbi.nlm.nih.gov/pubmed/31473598
http://dx.doi.org/10.1136/bmjebm-2019-111197
work_keys_str_mv AT dimengyang lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT maochen lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT yangzuyao lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT dinghong lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT liuqu lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT liushuiming lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT guohongbo lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT jiangkunhua lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial
AT tangjinling lackofeffectsofevidencebasedindividualisedcounsellingonmedicationuseininsuredpatientswithmildhypertensioninchinaarandomisedcontrolledtrial